Related Experiment Video
Updated: Jan 7, 2026

07:52
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
10.4K
Fibrin scaffolds for angiogenesis in soft tissue models: a systematic review
Carla Verónica Fuenteslópez1, Simge Bahcevanci1, Viorica Patrulea1,2,3
1Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, United Kingdom.
Bioactive Materials
|December 31, 2025
Summary
Fibrin scaffolds enhance soft tissue engineering by influencing angiogenesis. Human fibrinogen and pre-embedded cells improve outcomes, but reporting inconsistencies hinder clinical use.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Fibrin is a biocompatible and angiogenic biomaterial crucial for soft tissue engineering.
- Scaffold formulation and design significantly impact the success of fibrin-based therapies.
Purpose of the Study:
- To systematically review how fibrin scaffold composition and design influence angiogenesis in vitro and in vivo soft tissue models.
- To identify key parameters affecting endothelial cell behavior within fibrin scaffolds.
Main Methods:
- Systematic literature search of PubMed, Scopus, and OVID databases.
- Screening of 81 original studies by three independent researchers.
- Narrative synthesis of data on scaffold composition, design, cell embedding, and angiogenic outcomes.
- Assessment of risk of bias and study quality using established tools.
Main Results:
- Human-derived fibrinogen and pre-embedding cells consistently promoted successful angiogenic outcomes.
- Endothelial tube and network formation generally aligned, but migration patterns varied.
- Thrombin addition was often beneficial, while crosslinker effects were less conclusive.
- Muscle-specific studies predominantly utilized hydrogels and incorporated non-endothelial cells.
Conclusions:
- Fibrin scaffolds are vital for soft tissue engineering, with formulation and cell embedding being critical factors.
- Variability in experimental design and reporting standards impede reproducibility and clinical translation.
- A minimum information checklist and aggregated success rates are proposed to guide future research and scaffold design.
Related Concept Videos
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K

